Christopher O'Connor
@coconnormd
President, INOVA Heart and Vascular Institute || Professor,Duke University || Founding Editor,JACC-HF ll Past President -HFSA,Father 4 children.comments my own
ID: 3070253685
04-03-2015 17:02:25
2,2K Tweet
5,5K Followers
851 Following
Congratulations to Dr. Mitchell Psotka on being named a C3TI Champion 🏆 Mitchell Psotka Learn more about the program: search.app/7XbS2CBZMcbuLy…
Diversity in enrollment in VHD trials is stagnant. In TCTMD, Wayne Batchelor, MD adds his perspective on the critical role of early diagnosis Christopher O'Connor tctmd.com/news/valvular-….
New PUB in JACC Journals #JACCHF 🫀Heart Failure Drug Development Over the Eras: from the HFC Vanessa Blumer, MD, FACC James Januzzi Jr MD scottdavidsolomon 📖Read more about the evolution of HF drug development & contemporary approaches in HF trials sciencedirect.com/science/articl…
Dr. Robert M. Califf kicking off what is sure to be a provocative talk here Duke Health Fantastic to discuss with the Duke Heart family how we can do better for our patients
Thrilled to announce that Inova Schar Heart and Vascular has received the Mitral Foundation Mitral Valve Repair Reference Center Award for the 4th year in a row, in recognition of superior outcomes. Christopher O'Connor
Editorial in #JACCAdvances by JaredSpitzMD, L Nedda Dastmalchi DO, MA provides perspective on Nohara-Shitama et al approach to assessing relationship between dietary calcium & phosphorus with CAC & ECC doi.org/10.1016/j.jaca… jacc.org/doi/10.1016/j.…
More good news for pts living with HF with EF >|= 40%!! Positive top line results of FINEARTS trial with non-steroidal MRA Finerenone Looking forward to seeing full data at ESC!! European Society of Cardiology bayer.com/media/en-us/fi…
Performing live cases at the UW Community CTO event following #CRFInterventionalComplications was an excellent opportunity for Lindsey Cilia to showcase her outstanding skills and teach others Christopher O'Connor complications2024.crfconferences.com
Despite benefits in morbidity/mortality, utilization of GDMT remains low. A Minciunescu, Tariq Haddad, et all describe unique QI initiative to increase ARNI and MRA utilization in patients with HFrEF #JACCHF JACC Journals Christopher O'Connor jacc.org/doi/abs/10.101…
Success of ICIs in oncology treatment is counterbalanced by risk of ICI myocarditis. Ana Barac, MD, PhD, FACC, FAHA, Dr. Chris Defilippi discuss use of cTnI and cTnT for early diagnosis/risk stratification in #JACC:CardioOncology Viewpoint. jacc.org/doi/10.1016/j.…
Multistate model to predict risk of adverse events in patients with LVADs described by Palak Shah, et al in #JACCHF Shashank Sinha, MD, MSc, FACC, FAHA, FHFSA, Mitchell Psotka, Shashank Desai Christopher O'Connor jacc.org/doi/10.1016/j.…
Training the Next Generation of Data Monitoring Committee Members: An Initiative of the HFC is OUT NOW in the current issue of #jacchf JACC Journals Read more about HFC DMC training workshop and materials below ⬇️ jacc.org/doi/10.1016/j.…
Lp(a)-reducing therapeutics show promise to reduce CVD risk. In #JACC editorial, JaredSpitzMD Anandita Agarwala Kulkarni, MD FACC discuss O’Donoghue, M, et al study of off treatment effects of Olpasiran on Lp(a) jacc.org/doi/10.1016/j.… jacc.org/doi/10.1016/j.…
Registration Deadline August 30! Don’t miss -- All-star Faculty presenting Latest Research Results and Best Practices September 6-7 Inova Schar Heart and Vascular 2024 Cardiovascular Symposium. Brett Atwater Wayne Batchelor, MD Christopher O'Connor inovacvsymposium.com
IN PRESS NOW 🚨 Journal of Cardiac Failure What are the current challenges of LVAD implementation in Latin America? Read HFC members Vanessa Blumer, MD, FACC Christian Guilliod Grossmann, MD article about LVAD landscape and future direction at link below ⬇️ doi.org/10.1016/j.card…
New William & Mary undergraduates were urged to write their story… and find their calling in an inspirational welcome address by Inova Schar Heart and Vascular DEI Advisor, cardiologist and country music singer Dr. Cleve Francis Cleve Francis Christopher O'Connor bit.ly/3ZboRWG